Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.092 Q1 | 52 | 22 | 81 | 3347 | 270 | 74 | 4.46 | 152.14 | 53.85 | |
2 | Current Neuropharmacology | journal | 1.212 Q1 | 103 | 44 | 177 | 5733 | 573 | 168 | 3.30 | 130.30 | 39.57 | |
3 | Current Medicinal Chemistry | journal | 1.282 Q1 | 202 | 322 | 1293 | 39596 | 5384 | 1224 | 4.11 | 122.97 | 39.63 | |
4 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 | 39.76 | |
5 | Current Drug Targets | journal | 1.395 Q1 | 119 | 118 | 561 | 12855 | 1973 | 508 | 3.19 | 108.94 | 33.48 | |
6 | Recent Patents on CNS Drug Discovery | journal | 0.944 Q2 | 36 | 18 | 60 | 1928 | 133 | 51 | 2.14 | 107.11 | 40.98 | |
7 | Current Cancer Drug Targets | journal | 1.533 Q1 | 103 | 65 | 265 | 6080 | 1029 | 246 | 3.86 | 93.54 | 35.97 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 1.070 Q1 | 96 | 196 | 362 | 18231 | 990 | 313 | 2.50 | 93.02 | 38.01 | |
9 | Mini-Reviews in Medicinal Chemistry | journal | 0.769 Q2 | 107 | 95 | 412 | 8756 | 1381 | 393 | 3.20 | 92.17 | 45.98 | |
10 | Current Molecular Pharmacology | journal | 1.419 Q1 | 49 | 18 | 77 | 1656 | 261 | 69 | 2.78 | 92.00 | 38.64 | |
11 | Current Vascular Pharmacology | journal | 0.828 Q2 | 69 | 109 | 275 | 9714 | 772 | 247 | 2.46 | 89.12 | 37.10 | |
12 | Current Gene Therapy | journal | 1.503 Q1 | 80 | 45 | 141 | 3701 | 509 | 127 | 2.86 | 82.24 | 34.32 | |
13 | Current Topics in Medicinal Chemistry | journal | 1.149 Q1 | 133 | 234 | 703 | 18714 | 2544 | 624 | 3.31 | 79.97 | 39.50 | |
14 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 20 | 62 | 1585 | 93 | 56 | 1.16 | 79.25 | 21.43 | ||
15 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.963 Q2 | 108 | 144 | 409 | 11251 | 1144 | 375 | 2.65 | 78.13 | 40.47 | |
16 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.631 Q2 | 28 | 23 | 73 | 1754 | 186 | 70 | 2.33 | 76.26 | 45.88 | |
17 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 27 | 68 | 1907 | 115 | 65 | 1.76 | 70.63 | 47.13 | ||
18 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 40 | 128 | 2804 | 241 | 121 | 1.79 | 70.10 | 30.22 | ||
19 | Current Drug Discovery Technologies | journal | 0.668 Q2 | 49 | 26 | 105 | 1787 | 227 | 96 | 1.64 | 68.73 | 32.95 | |
20 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 9 | 74 | 585 | 153 | 69 | 2.00 | 65.00 | 50.00 | ||
21 | Reviews on Recent Clinical Trials | journal | 0.520 Q3 | 35 | 40 | 93 | 2503 | 152 | 87 | 1.60 | 62.58 | 35.71 | |
22 | Current Drug Delivery | journal | 0.599 Q2 | 72 | 74 | 212 | 4622 | 439 | 203 | 1.72 | 62.46 | 33.49 | |
23 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.660 Q2 | 45 | 33 | 67 | 2056 | 110 | 62 | 1.78 | 62.30 | 40.00 | |
24 | Current Drug Therapy | journal | 0.154 Q3 | 20 | 23 | 90 | 1402 | 40 | 85 | 0.32 | 60.96 | 37.50 | |
25 | Current Bioactive Compounds | journal | 0.246 Q2 | 31 | 29 | 103 | 1736 | 84 | 91 | 0.64 | 59.86 | 37.89 | |
26 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.532 Q3 | 43 | 26 | 99 | 1555 | 137 | 92 | 1.21 | 59.81 | 33.33 | |
27 | Open Medicinal Chemistry Journal | journal | 0.743 Q1 | 23 | 4 | 24 | 233 | 78 | 23 | 1.45 | 58.25 | 38.46 | |
28 | Infectious Disorders - Drug Targets | journal | 0.808 Q2 | 61 | 33 | 133 | 1828 | 251 | 120 | 1.72 | 55.39 | 36.52 | |
29 | Current Pharmacogenomics and Personalized Medicine | journal | 0.220 Q3 | 20 | 16 | 109 | 867 | 84 | 86 | 0.62 | 54.19 | 41.18 | |
30 | Current Computer-Aided Drug Design | journal | 0.380 Q3 | 32 | 36 | 113 | 1849 | 172 | 101 | 1.21 | 51.36 | 35.25 | |
31 | International Journal of Genomics | journal | 0.341 Q2 | 37 | 46 | 44 | 2307 | 43 | 43 | 0.98 | 50.15 | 35.84 | |
32 | Anti-Infective Agents | journal | 0.174 Q4 | 26 | 21 | 42 | 1038 | 21 | 40 | 0.50 | 49.43 | 41.67 | |
33 | Current Drug Safety | journal | 0.424 Q3 | 41 | 35 | 159 | 1681 | 252 | 149 | 1.42 | 48.03 | 42.76 | |
34 | Journal of Toxicology | journal | 0.890 Q2 | 47 | 33 | 135 | 1508 | 435 | 131 | 2.68 | 45.70 | 32.31 | |
35 | Medicinal Chemistry | journal | 0.420 Q3 | 50 | 86 | 337 | 3856 | 488 | 329 | 1.33 | 44.84 | 39.71 | |
36 | Current Enzyme Inhibition | journal | 0.212 Q4 | 19 | 16 | 55 | 683 | 27 | 49 | 0.43 | 42.69 | 41.51 | |
37 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.154 Q3 | 10 | 9 | 38 | 344 | 11 | 38 | 0.17 | 38.22 | 46.15 | |
38 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.206 Q3 | 17 | 18 | 94 | 683 | 42 | 88 | 0.34 | 37.94 | 41.94 | |
39 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.274 Q3 | 27 | 24 | 100 | 910 | 91 | 88 | 1.31 | 37.92 | 32.20 | |
40 | Combinatorial Chemistry and High Throughput Screening | journal | 0.475 Q3 | 70 | 96 | 270 | 3538 | 450 | 250 | 1.33 | 36.85 | 44.48 | |
41 | Current Pharmaceutical Analysis | journal | 0.243 Q3 | 27 | 36 | 129 | 1263 | 102 | 127 | 0.82 | 35.08 | 39.10 | |
42 | Open Drug Discovery Journal | journal | 10 | 1 | 0 | 33 | 0 | 0 | 0.00 | 33.00 | 0.00 | ||
43 | Current Radiopharmaceuticals | journal | 0.589 Q2 | 32 | 20 | 111 | 651 | 193 | 103 | 1.75 | 32.55 | 41.76 | |
44 | Letters in Drug Design and Discovery | journal | 0.241 Q3 | 37 | 135 | 392 | 4348 | 303 | 387 | 0.85 | 32.21 | 38.18 | |
45 | Jordan Journal of Pharmaceutical Sciences | journal | 0.155 Q3 | 12 | 19 | 70 | 570 | 22 | 70 | 0.23 | 30.00 | 46.55 | |
46 | Current Nanoscience | journal | 0.350 Q2 | 52 | 136 | 397 | 3897 | 499 | 388 | 1.19 | 28.65 | 27.58 | |
47 | Drug Metabolism Letters | journal | 0.306 Q2 | 31 | 17 | 92 | 483 | 97 | 90 | 0.91 | 28.41 | 40.26 | |
48 | Current Clinical Pharmacology | journal | 0.603 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
49 | Recent Patents on Drug Delivery and Formulation | journal | 0.469 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
50 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.431 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®